Jing Cheng

Dr. Jing Cheng

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YLYan Li
Yan Li
PSPuhan Song
Puhan Song
MZMengyi Zheng
Mengyi Zheng
YJYanyao Jia
Yanyao Jia
JWJuan Wang
Juan Wang
JCJing Cheng
Jing Cheng
Background: The triglyceride–glucose (TyG) index is a simple surrogate marker of insulin resistance (IR) and has been associated with coronary artery disease (CAD). However, the association between the TyG index and coronary chronic total occlusion (CTO) remains limited. Methods: In this retrospective study, 1157 patients who underwent coronary angiography at Beijing Chaoyang Hospital from January 2024 to January 2026 were enrolled and classified into the CTO group (n = 317) and the non-CTO group (n = 840). Multivariable logistic regression analyses were performed to assess the association between the TyG index and CTO. Restricted cubic spline analysis was used to examine the linear dose–response relationship. Subgroup analyses were conducted according to age, sex, smoking status, hypertension, and diabetes mellitus. Results: Patients with CTO had a significantly higher TyG index than those without CTO (8.98 [8.46, 9.45] vs. 8.79 [8.41, 9.26], p = 0.003). In the multivariable logistic regression analysis, the TyG index was independently associated with the presence of CTO (OR = 1.377, 95% CI 1.082–1.752, p = 0.009). In a sensitivity analysis further adjusted for diabetes mellitus, the association remained significant (OR = 1.356, 95% CI 1.052–1.747, p = 0.018). Restricted cubic spline curve analysis showed a nonlinear dose–response relationship (p for nonlinear = 0.005) between the TyG index and CTO risk. In the subgroup analyses, the association was directionally consistent across subgroups. Nominally significant associations were observed in elderly participants (OR 1.68, 95% CI 1.20–2.37, p = 0.003), men (OR 1.40, 95% CI 1.06–1.86, p = 0.018), and patients with hypertension (OR 1.55, 95% CI 1.14–2.11, p = 0.005). Conclusions: An elevated TyG index was independently associated with the presence of CTO. The association was generally consistent across major clinical subgroups, with no significant interactions observed.

27 May 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
BQBingyang Qi
Bingyang Qi
MLMengyang Liu
Mengyang Liu
XYXin Yi
Xin Yi
YJYanyao Jia
Yanyao Jia
YTYahang Tan
Yahang Tan
LZLin Zhao
Lin Zhao
Background: Chronic total occlusion (CTO) represents one of the most challenging lesion subsets in coronary artery disease, and antegrade recanalization (AR) is the preferred approach for revascularization due to its lower complication risk. However, predicting AR success remains clinically difficult. The Advanced Lung Cancer Inflammation Index (ALI), integrating body mass index, albumin, and neutrophil-to-lymphocyte ratio, reflects nutritional and inflammatory status, both of which may influence procedural outcomes. This study aimed to investigate the association between ALI and successful AR in CTO patients undergoing percutaneous coronary intervention (PCI). Methods: In this retrospective cross-sectional study, 198 patients with angiographically confirmed CTO undergoing PCI between May 2024 and December 2025 were analyzed. Patients were stratified into successful AR (n = 132) and failed AR (n = 66) groups based on the final recanalization route. ALI was calculated preprocedurally. Multivariable logistic regression, generalized additive modeling (GAM), and subgroup and sensitivity analyses were performed to examine the association between ALI and AR success. Receiver operating characteristic (ROC) curves were used to evaluate the predictive capability of ALI and the Japanese CTO Registry (J-CTO) score for successful AR, with DeLong’ s test to compare model differences. Confusion matrix parameters were also used to assess model performance. Results: Patients in the successful AR group had significantly lower ALI values than those in the failed group (P = 0.012). Higher ALI was independently associated with lower odds of AR success in both unadjusted (OR = 0.624; 95% CI, 0.437–0.859; P = 0.006) and fully adjusted models (OR = 0.622; 95% CI, 0.416–0.879; P = 0.013). GAM confirmed an approximately linear inverse relationship between ALI and AR success (P = 0.013). Subgroup analyses showed consistent associations across clinical strata, with particularly strong effects in males and patients with prior PCI or MI. Sensitivity analysis revealed a significant dose–response trend across ALI quartiles (P for trend = 0.021), with the highest ALI quartile associated with significantly lower AR success (OR = 0.318; 95% CI, 0.121–0.96; P = 0.017). ROC curve analysis demonstrated that ALI alone had fair predictive performance for AR success (AUC = 0.608; 95% CI, 0.524–0.692), with high specificity (0.970) but low sensitivity (0.106; F1 = 0.182). The J-CTO score improved discrimination (AUC = 0.760; 95% CI, 0.696–0.823), and combining ALI with J-CTO further enhanced predictive ability (AUC = 0.798; 95% CI, 0.736–0.860; sensitivity = 0.439, specificity = 0.864, F1 = 0.513). DeLong’ s test confirmed a statistically significant AUC improvement for the combined model versus J-CTO alone (ΔAUC = 0.038; 95% CI, 0.007–0.069; P = 0.017), indicating additional prognostic value of ALI. Conclusions: ALI is independently and inversely associated with the success of AR in CTO lesions. As a composite biomarker of inflammation and nutrition, ALI may help identify patients with lower probability of AR success and, when combined with the J-CTO score, enhance preprocedural assessment and procedural planning.